A detailed history of Roberts Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Roberts Capital Advisors, LLC holds 3,693 shares of ABT stock, worth $423,808. This represents 0.36% of its overall portfolio holdings.

Number of Shares
3,693
Previous 3,693 -0.0%
Holding current value
$423,808
Previous $383,000 9.92%
% of portfolio
0.36%
Previous 0.37%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $29,132 - $32,175
-266 Reduced 6.72%
3,693 $419,000
Q4 2021

Feb 15, 2022

BUY
$115.53 - $141.46 $457,383 - $560,040
3,959 New
3,959 $557,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Roberts Capital Advisors, LLC Portfolio

Follow Roberts Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roberts Capital Advisors, LLC with notifications on news.